Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

1839

Actual shortage: 46 (3%)
Anticipated shortage: 1 (0%)
Avoided shortage: 13 (1%)
Resolved: 1779 (97%)

Discontinuation Reports

82

To be discontinued: 1 (1%)
Discontinued: 79 (96%)
Reversed: 2 (2%)

Late reports

439 (23%)

Overdue reports

1 (2%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2021-07-26 2021-08-03 143001
SANDOZ MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2021-11-29 2021-12-21 150164
SANDOZ MONTELUKAST 4MG GRANULES Resolved 2022-09-01 2022-11-16 168455
SANDOZ MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2023-06-05 2023-06-06 193742
SANDOZ MONTELUKAST 4MG GRANULES Resolved 2021-12-06 2022-02-18 150582
SANDOZ MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2021-10-25 2021-11-16 147911
SANDOZ MORPHINE SR 60MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-13 2023-02-09 158717
SANDOZ MORPHINE SR 200MG TABLET (EXTENDED-RELEASE) Resolved 2022-08-18 2023-03-28 167317
SANDOZ MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-28 2023-02-09 176026
SANDOZ MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-09 2023-03-06 184255
SANDOZ MOXIFLOXACIN 0.5% SOLUTION Resolved 2017-05-15 2017-06-26 10329
SANDOZ MOXIFLOXACIN 0.5% SOLUTION Resolved 2020-07-02 2020-09-21 119335
SANDOZ MOXIFLOXACIN 0.5% SOLUTION Resolved 2021-12-20 2022-01-18 151597
SANDOZ MOXIFLOXACIN 0.5% SOLUTION Resolved 2024-03-11 2024-04-04 221835
SANDOZ MYCOPHENOLATE MOFETIL 500MG TABLET Resolved 2022-04-20 2022-04-28 159082
SANDOZ MYCOPHENOLATE MOFETIL 500MG TABLET Resolved 2022-09-21 2022-09-28 169667
SANDOZ MYCOPHENOLATE MOFETIL 500MG TABLET Resolved 2022-10-19 2022-10-26 172169
SANDOZ MYCOPHENOLATE MOFETIL 500MG TABLET Resolved 2023-01-31 2023-02-09 182816
SANDOZ MYCOPHENOLATE MOFETIL 500MG TABLET Resolved 2023-05-25 2023-06-20 193049
NALOXONE HCL INJECTION - 1MG/ML USP 1MG LIQUID Resolved 2022-10-19 2022-12-29 172174

Showing 1281 to 1300 of 1839

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
SANDOZ ALENDRONATE 10MG TABLET Discontinued 2019-11-19 2019-11-19 99259
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
SODIUM AUROTHIOMALATE INJECTION BP 50MG SOLUTION Discontinued 2018-07-13 2018-07-13 55768
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
SANDOZ DILTIAZEM T Discontinued 2020-04-01 2020-04-01 110324
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
SANDOZ FINASTERIDE A 1MG TABLET Discontinued 2023-06-30 2023-07-01 196983
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467

Showing 1 to 20 of 82